https://www.novartis.com/ | Anchor | Skip to main content |
https://www.novartis.com/ | | IMG-ALT Novartis |
https://www.novartis.com/ | Anchor | International |
https://www.novartis.com/ | Anchor | Americas |
https://www.novartis.com/ | Anchor | Asia Pacific |
https://www.novartis.com/ | Anchor | Europe |
https://www.novartis.com/ | Anchor | Middle East & Africa |
https://www.novartis.com/ | Subdomain | Global | English |
https://www.novartisfoundation... | Extern Subdomain | Novartis Foundation | English |
https://www.novartis.com/ar-es/ | Subdomain | Argentina | Español |
https://www.novartis.com/br-pt/ | Subdomain | Brazil | Português |
https://www.novartis.com/ca-en/ | Subdomain | Canada | English |
https://www.novartis.com/ca-fr/ | Subdomain | Canada | Français |
/candean-es/ | Subdomain | Central America | Español |
https://www.novartis.com/co-es/ | Subdomain | Colombia | Español |
https://www.novartis.com/mx-es/ | Subdomain | Mexico | Español |
https://www.novartis.com/us-en/ | Subdomain | United States | English |
https://www.novartis.com/au-en/ | Subdomain | Australia | English |
https://www.novartis.com/bd-en/ | Subdomain | Bangladesh | English |
https://www.novartis.com/hk-zh/ | Subdomain | Hong Kong S.A.R. | 繁體中文 |
https://www.novartis.com/in-en/ | Subdomain | India | English |
https://www.novartis.com/id-en/ | Subdomain | Indonesia | English |
https://www.novartis.com/jp-ja/ | Subdomain | Japan | 日本語 |
https://www.novartis.com/kr-ko/ | Subdomain | Korea | 한국어 |
https://www.novartis.com.cn/ | Extern Subdomain | Mainland China | 中文 |
https://www.novartis.com/my-en/ | Subdomain | Malaysia | English |
https://www.novartis.com/pk-en/ | Subdomain | Pakistan | English |
https://www.novartis.com/ph-en/ | Subdomain | Philippines | English |
https://www.novartis.com/sg-en/ | Subdomain | Singapore | English |
https://www.novartis.com/tw-zh/ | Subdomain | Taiwan | 繁體中文 |
https://www.novartis.com/th-th/ | Subdomain | Thailand | ภาษาไทย |
https://www.novartis.com/at-de/ | Subdomain | Austria | Deutsch |
https://www.novartis.com/be-fr/ | Subdomain | Belgium | Français |
https://www.novartis.com/be-nl/ | Subdomain | Belgium | Nederlands |
https://www.novartis.com/bg-bg/ | Subdomain | Bulgaria | Български |
https://www.novartis.com/cz-cs/ | Subdomain | Czech Republic | Česky |
https://www.novartis.com/cz-en/ | Subdomain | Czech Republic | English |
https://www.novartis.com/dk-da/ | Subdomain | Denmark | Dansk |
https://www.novartis.com/ee-et/ | Subdomain | Estonia | Eesti |
https://www.novartis.com/fi-fi/ | Subdomain | Finland | Suomalainen |
https://www.novartis.com/fr-fr/ | Subdomain | France | Français |
https://www.novartis.com/de-de/ | Subdomain | Germany | Deutsch |
https://www.novartis.com/gr-el/ | Subdomain | Greece | Ελληνικά |
https://www.novartis.com/hu-hu/ | Subdomain | Hungary | Magyar |
https://www.novartis.com/ie-en/ | Subdomain | Ireland | English |
https://www.novartis.com/it-it/ | Subdomain | Italy | Italiano |
https://www.novartis.com/lv-lv/ | Subdomain | Latvia | Latvian |
https://www.novartis.com/lt-lt/ | Subdomain | Lithuania | Lithuanian |
https://www.novartis.com/nl-nl/ | Subdomain | Netherlands | Nederlands |
https://www.novartis.com/no-no/ | Subdomain | Norway | Norsk |
https://www.novartis.com/pl-pl/ | Subdomain | Poland | Polski |
https://www.novartis.com/pt-pt/ | Subdomain | Portugal | Português |
https://www.novartis.com/ro-ro/ | Subdomain | Romania | Română |
https://www.novartis.com/ru-ru/ | Subdomain | Russia | Русский |
https://www.novartis.com/rs-sr/ | Subdomain | Serbia | Srpski |
https://www.novartis.com/sk-sk/ | Subdomain | Slovakia | Slovensky |
https://www.novartis.com/si-sl/ | Subdomain | Slovenia | Slovenščina |
https://www.novartis.com/si-en/ | Subdomain | Slovenia | English |
https://www.novartis.com/es-es/ | Subdomain | Spain | Español |
https://www.novartis.com/se-se/ | Subdomain | Sweden | Svenska |
https://www.novartis.com/ch-de/ | Subdomain | Switzerland | Deutsch |
https://www.novartis.com/ch-fr/ | Subdomain | Switzerland | Français |
https://www.novartis.com/tr-tr/ | Subdomain | Türkiye | Türkçe |
https://www.novartis.com/uk-en/ | Subdomain | United Kingdom | English |
https://www.novartis.com/eg-en/ | Subdomain | Egypt | English |
https://www.novartis.com/il-he/ | Subdomain | Israel | עברית |
https://www.novartis.com/sa-ar/ | Subdomain | Saudi Arabia | العربية |
https://www.novartis.com/za-en/ | Subdomain | South Africa | English |
https://www.novartis.com/ | Anchor Textduplikat | International |
https://www.novartis.com/ | Anchor Textduplikat | Americas |
https://www.novartis.com/ | Anchor Textduplikat | Asia Pacific |
https://www.novartis.com/ | Anchor Textduplikat | Europe |
https://www.novartis.com/ | Anchor Textduplikat | Middle East & Africa |
https://www.novartis.com/ar-es/ | Subdomain Textduplikat | Argentina | Español |
https://www.novartis.com/au-en/ | Subdomain Textduplikat | Australia | English |
https://www.novartis.com/at-de/ | Subdomain Textduplikat | Austria | Deutsch |
https://www.novartis.com/bd-en/ | Subdomain Textduplikat | Bangladesh | English |
https://www.novartis.com/be-fr/ | Subdomain Textduplikat | Belgium | Français |
https://www.novartis.com/be-nl/ | Subdomain Textduplikat | Belgium | Nederlands |
https://www.novartis.com/br-pt/ | Subdomain Textduplikat | Brazil | Português |
https://www.novartis.com/bg-bg/ | Subdomain Textduplikat | Bulgaria | Български |
https://www.novartis.com/ca-en/ | Subdomain Textduplikat | Canada | English |
https://www.novartis.com/ca-fr/ | Subdomain Textduplikat | Canada | Français |
/candean-es/ | Subdomain Textduplikat | Central America | Español |
https://www.novartis.com/co-es/ | Subdomain Textduplikat | Colombia | Español |
https://www.novartis.com/cz-cs/ | Subdomain Textduplikat | Czech Republic | Česky |
https://www.novartis.com/cz-en/ | Subdomain Textduplikat | Czech Republic | English |
https://www.novartis.com/dk-da/ | Subdomain Textduplikat | Denmark | Dansk |
https://www.novartis.com/eg-en/ | Subdomain Textduplikat | Egypt | English |
https://www.novartis.com/ee-et/ | Subdomain Textduplikat | Estonia | Eesti |
https://www.novartis.com/fi-fi/ | Subdomain Textduplikat | Finland | Suomalainen |
https://www.novartis.com/fr-fr/ | Subdomain Textduplikat | France | Français |
https://www.novartis.com/de-de/ | Subdomain Textduplikat | Germany | Deutsch |
https://www.novartis.com/gr-el/ | Subdomain Textduplikat | Greece | Ελληνικά |
https://www.novartis.com/hk-zh/ | Subdomain Textduplikat | Hong Kong S.A.R. | 繁體中文 |
https://www.novartis.com/hu-hu/ | Subdomain Textduplikat | Hungary | Magyar |
https://www.novartis.com/in-en/ | Subdomain Textduplikat | India | English |
https://www.novartis.com/id-en/ | Subdomain Textduplikat | Indonesia | English |
https://www.novartis.com/ie-en/ | Subdomain Textduplikat | Ireland | English |
https://www.novartis.com/il-he/ | Subdomain Textduplikat | Israel | עברית |
https://www.novartis.com/it-it/ | Subdomain Textduplikat | Italy | Italiano |
https://www.novartis.com/jp-ja/ | Subdomain Textduplikat | Japan | 日本語 |
https://www.novartis.com/kr-ko/ | Subdomain Textduplikat | Korea | 한국어 |
https://www.novartis.com/lv-lv/ | Subdomain Textduplikat | Latvia | Latvian |
https://www.novartis.com/lt-lt/ | Subdomain Textduplikat | Lithuania | Lithuanian |
https://www.novartis.com.cn/ | Extern Subdomain Textduplikat | Mainland China | 中文 |
https://www.novartis.com/my-en/ | Subdomain Textduplikat | Malaysia | English |
https://www.novartis.com/mx-es/ | Subdomain Textduplikat | Mexico | Español |
https://www.novartis.com/nl-nl/ | Subdomain Textduplikat | Netherlands | Nederlands |
https://www.novartis.com/no-no/ | Subdomain Textduplikat | Norway | Norsk |
https://www.novartis.com/ | Subdomain Textduplikat | Global | English |
https://www.novartisfoundation... | Extern Subdomain Textduplikat | Novartis Foundation | English |
https://www.novartis.com/pk-en/ | Subdomain Textduplikat | Pakistan | English |
https://www.novartis.com/ph-en/ | Subdomain Textduplikat | Philippines | English |
https://www.novartis.com/pl-pl/ | Subdomain Textduplikat | Poland | Polski |
https://www.novartis.com/pt-pt/ | Subdomain Textduplikat | Portugal | Português |
https://www.novartis.com/ro-ro/ | Subdomain Textduplikat | Romania | Română |
https://www.novartis.com/ru-ru/ | Subdomain Textduplikat | Russia | Русский |
https://www.novartis.com/sa-ar/ | Subdomain Textduplikat | Saudi Arabia | العربية |
https://www.novartis.com/rs-sr/ | Subdomain Textduplikat | Serbia | Srpski |
https://www.novartis.com/sg-en/ | Subdomain Textduplikat | Singapore | English |
https://www.novartis.com/sk-sk/ | Subdomain Textduplikat | Slovakia | Slovensky |
https://www.novartis.com/si-sl/ | Subdomain Textduplikat | Slovenia | Slovenščina |
https://www.novartis.com/si-en/ | Subdomain Textduplikat | Slovenia | English |
https://www.novartis.com/za-en/ | Subdomain Textduplikat | South Africa | English |
https://www.novartis.com/es-es/ | Subdomain Textduplikat | Spain | Español |
https://www.novartis.com/se-se/ | Subdomain Textduplikat | Sweden | Svenska |
https://www.novartis.com/ch-de/ | Subdomain Textduplikat | Switzerland | Deutsch |
https://www.novartis.com/ch-fr/ | Subdomain Textduplikat | Switzerland | Français |
https://www.novartis.com/tw-zh/ | Subdomain Textduplikat | Taiwan | 繁體中文 |
https://www.novartis.com/th-th/ | Subdomain Textduplikat | Thailand | ภาษาไทย |
https://www.novartis.com/tr-tr/ | Subdomain Textduplikat | Türkiye | Türkçe |
https://www.novartis.com/uk-en/ | Subdomain Textduplikat | United Kingdom | English |
https://www.novartis.com/us-en/ | Subdomain Textduplikat | United States | English |
https://www.novartis.com/about | | About A-TITLE About |
/about/board-directors | | Board of Directors A-TITLE Board of Directors |
/about/board-directors/joerg-r... | | Joerg Reinhardt A-TITLE Joerg Reinhardt |
/about/board-directors/simon-m... | | Simon Moroney A-TITLE Simon Moroney |
/about/board-directors/nancy-c... | | Nancy C. Andrews A-TITLE Nancy C. Andrews |
/about/board-directors/ton-bue... | | Ton Buechner A-TITLE Ton Buechner |
/about/board-directors/patrice... | | Patrice Bula A-TITLE Patrice Bula |
/about/board-directors/elizabe... | | Elizabeth (Liz) Doherty A-TITLE Elizabeth (Liz) Doherty |
/about/board-directors/ana-de-... | | Ana de Pro Gonzalo A-TITLE Ana de Pro Gonzalo |
/about/board-directors/bridget... | | Bridgette Heller A-TITLE Bridgette Heller |
/about/board-directors/daniel-... | | Daniel Hochstrasser A-TITLE Daniel Hochstrasser |
/about/board-directors/frans-v... | | Frans van Houten A-TITLE Frans van Houten |
/about/board-directors/charles... | | Charles L. Sawyers A-TITLE Charles L. Sawyers |
/about/board-directors/william... | | William T. Winters A-TITLE William T. Winters |
/about/board-directors/john-d-... | | John D. Young A-TITLE John D. Young |
/about/board-directors/charlot... | | Charlotte Pamer-Wieser A-TITLE Charlotte Pamer-Wieser |
/about/executive-committee | | Executive Committee A-TITLE Executive Committee |
/about/executive-committee/vas... | | Vasant (Vas) Narasimhan A-TITLE Vasant (Vas) Narasimhan |
/about/executive-committee/shr... | | Shreeram Aradhye A-TITLE Shreeram Aradhye |
/about/executive-committee/vic... | | Victor Bulto A-TITLE Victor Bulto |
/about/executive-committee/aha... | | Aharon (Ronny) Gal A-TITLE Aharon (Ronny) Gal |
/about/executive-committee/kar... | | Karen L. Hale A-TITLE Karen L. Hale |
/about/executive-committee/pat... | | Patrick Horber A-TITLE Patrick Horber |
/about/executive-committee/har... | | Harry Kirsch A-TITLE Harry Kirsch |
/about/executive-committee/rob... | | Rob Kowalski A-TITLE Rob Kowalski |
/about/executive-committee/ste... | | Steffen Lang A-TITLE Steffen Lang |
/about/executive-committee/fio... | | Fiona Marshall A-TITLE Fiona Marshall |
/about/executive-committee/kla... | | Klaus Moosmayer A-TITLE Klaus Moosmayer |
/about/executive-committee/lut... | | Lutz Hegemann A-TITLE Lutz Hegemann |
/about/executive-committee/kee... | | Kees Roks A-TITLE Kees Roks |
/about/executive-committee/mic... | | Michelle Weese A-TITLE Michelle Weese |
/about/products | | Products A-TITLE Products |
/about/therapeutic-areas | | Therapeutic areas A-TITLE Therapeutic areas |
/about/therapeutic-areas/cardi... | | Cardiovascular, renal and metabolic A-TITLE Cardiovascular, renal and metabolic |
/about/therapeutic-areas/immun... | | Immunology A-TITLE Immunology |
/about/therapeutic-areas/neuro... | | Neuroscience A-TITLE Neuroscience |
/about/therapeutic-areas/oncology | | Oncology A-TITLE Oncology |
/about/people-and-culture | | People and culture A-TITLE People and culture |
/about/diversity-equity-and-in... | | Diversity, equity and inclusion A-TITLE Diversity, equity and inclusion |
/about/diversity-equity-and-in... | | Equity A-TITLE Equity |
/about/diversity-equity-and-in... | | Inclusivity A-TITLE Inclusivity |
/about/diversity-equity-and-in... | | Parental leave A-TITLE Parental leave |
/about/diversity-equity-and-in... | | Society A-TITLE Society |
/about/novartis-gene-therapies | | Novartis Gene Therapies A-TITLE Novartis Gene Therapies |
/about/manufacturing | | Manufacturing A-TITLE Manufacturing |
/about/quality | | Quality A-TITLE Quality |
/about/quality/audit-program | | Audit program A-TITLE Audit program |
/about/quality/novartis-qualit... | | Novartis quality management system (QMS) A-TITLE Novartis quality management system (QMS) |
/about/quality/product-and-pat... | | Product and patient safety training A-TITLE Product and patient safety training |
/about/quality/regulatory-insp... | | Regulatory inspections A-TITLE Regulatory inspections |
/about/quality/product-recalls | | Product recalls A-TITLE Product recalls |
/about/quality/third-party-sup... | | Third-party suppliers A-TITLE Third-party suppliers |
/about/awards-and-recognition | | Awards and recognition A-TITLE Awards and recognition |
/patients-and-caregivers | | Patients and caregivers A-TITLE Patients and caregivers |
/patients-and-caregivers/novar... | | Novartis commitment to patients and caregivers A-TITLE Novartis commitment to patients and caregivers |
https://www.novartis.com/diseases | | Diseases A-TITLE Diseases |
/investors/reporting-and-trans... | | Patient organization funding A-TITLE Patient organization funding |
/news/stories/patient-perspect... | | Patients perspectives stories A-TITLE Patients perspectives stories |
/healthcare-professionals | | Healthcare professionals A-TITLE Healthcare professionals |
/healthcare-professionals/medi... | | Medical congresses and events A-TITLE Medical congresses and events |
/healthcare-professionals/medi... | | ASCO Annual Meeting A-TITLE ASCO Annual Meeting |
/about/products | Textduplikat | Products A-TITLE Products |
/research-development/novartis... | | Novartis pipeline A-TITLE Novartis pipeline |
/healthcare-professionals/mana... | | Managed access programs A-TITLE Managed access programs |
/healthcare-professionals/mana... | | Zolgensma® Global Managed Access Program (gMAP) A-TITLE Zolgensma® Global Managed Access Program (gMAP) |
/healthcare-professionals/nova... | | Novartis external funding A-TITLE Novartis external funding |
/healthcare-professionals/heal... | | Healthcare professional resources by country A-TITLE Healthcare professional resources by country |
/healthcare-professionals/inve... | | Investigator-initiated trials / studies A-TITLE Investigator-initiated trials / studies |
/healthcare-professionals/nova... | | Novartis medical information A-TITLE Novartis medical information |
/healthcare-professionals/nova... | | Submit medical enquiry A-TITLE Submit medical enquiry |
/research-and-development | | Research and development A-TITLE Research and development |
/research-and-development/tech... | | Technology platforms A-TITLE Technology platforms |
/research-and-development/rese... | | Research disease areas A-TITLE Research disease areas |
/research-and-development/rese... | | Cardiovascular and metabolic disease research at Novartis A-TITLE Cardiovascular and metabolic disease research at Novartis |
/research-and-development/rese... | | DAx: exploratory disease research at Novartis A-TITLE DAx: exploratory disease research at Novartis |
/research-and-development/rese... | | Global Health disease area research at Novartis A-TITLE Global Health disease area research at Novartis |
/research-and-development/rese... | | Immunology disease research at Novartis A-TITLE Immunology disease research at Novartis |
/research-and-development/rese... | | Neuroscience research at Novartis A-TITLE Neuroscience research at Novartis |
/research-and-development/rese... | | Oncology research at Novartis A-TITLE Oncology research at Novartis |
/research-and-development/rese... | | Ophthalmology research at Novartis A-TITLE Ophthalmology research at Novartis |
/research-development/novartis... | Textduplikat | Novartis pipeline A-TITLE Novartis pipeline |
/research-and-development/rese... | | Research collaborations A-TITLE Research collaborations |
/research-and-development/coll... | | Collaborations A-TITLE Collaborations |
https://www.novartis.com/esg | | ESG A-TITLE ESG |
/esg/access | | Access A-TITLE Access |
/esg/access/creating-sustainab... | | Creating sustainable business models A-TITLE Creating sustainable business models |
/esg/access/value-based-pricing | | Value-based pricing A-TITLE Value-based pricing |
/esg/access/sub-saharan-africa | | Sub-Saharan Africa A-TITLE Sub-Saharan Africa |
/esg/access/donations | | Donations A-TITLE Donations |
/esg/access/novartis-access-pr... | | Novartis access principles A-TITLE Novartis access principles |
/esg/access/novartis-oncology-... | | Novartis oncology access A-TITLE Novartis oncology access |
/esg/access/patents-and-licensing | | Patents and licensing A-TITLE Patents and licensing |
/esg/environmental-sustainability | | Environmental sustainability A-TITLE Environmental sustainability |
/esg/environmental-sustainabil... | | Climate A-TITLE Climate |
/esg/environmental-sustainabil... | | Waste A-TITLE Waste |
/esg/environmental-sustainabil... | | Water A-TITLE Water |
/esg/ethics-risk-and-compliance | | Ethics, risk and compliance A-TITLE Ethics, risk and compliance |
/esg/ethics-risk-and-complianc... | | Ethical behavior A-TITLE Ethical behavior |
/esg/ethics-risk-and-complianc... | | Compliance A-TITLE Compliance |
/esg/ethics-risk-and-complianc... | | Human rights A-TITLE Human rights |
/esg/ethics-risk-and-complianc... | | Learning and engagement A-TITLE Learning and engagement |
/esg/ethics-risk-and-complianc... | | Integrated risk assurance A-TITLE Integrated risk assurance |
/esg/global-health | | Global health A-TITLE Global health |
/esg/global-health/pandemic-pr... | | Pandemic preparedness A-TITLE Pandemic preparedness |
/esg/global-health/avoidable-b... | | Avoidable blindness A-TITLE Avoidable blindness |
/diseases/chagas-disease | | Chagas disease A-TITLE Chagas disease |
/diseases/leprosy | | Leprosy A-TITLE Leprosy |
/diseases/malaria | | Malaria A-TITLE Malaria |
/diseases/sickle-cell-disease | | Sickle cell disease (SCD) A-TITLE Sickle cell disease (SCD) |
https://www.novartisfoundation... | Neues Fenster Extern Subdomain | Novartis Foundation A-TITLE Novartis Foundation |
/about/diversity-equity-and-in... | Textduplikat | Diversity, equity and inclusion A-TITLE Diversity, equity and inclusion |
/esg/index | | ESG index A-TITLE ESG index |
/investors/reporting-and-trans... | | Reporting and transparency hub A-TITLE Reporting and transparency hub |
/investors/reporting-and-trans... | | Novartis in Society Integrated Report A-TITLE Novartis in Society Integrated Report |
/investors/reporting-and-trans... | | ESG rating performance A-TITLE ESG rating performance |
/investors/reporting-and-trans... | | Targets A-TITLE Targets |
/investors/reporting-and-trans... | Textduplikat | Patient organization funding A-TITLE Patient organization funding |
/investors/reporting-and-trans... | | Payments to healthcare professionals A-TITLE Payments to healthcare professionals |
/investors/reporting-and-trans... | | Public policy A-TITLE Public policy |
/investors/reporting-and-trans... | | A living wage A-TITLE A living wage |
/investors/reporting-and-trans... | | A safe workplace A-TITLE A safe workplace |
/investors/reporting-and-trans... | | Animal research A-TITLE Animal research |
/investors | | Investors A-TITLE Investors |
/investors/event-calendar | | Event calendar A-TITLE Event calendar |
/investors/financial-data | | Financial data A-TITLE Financial data |
/investors/financial-data/annu... | | Novartis annual results A-TITLE Novartis annual results |
/investors/financial-data/quar... | | Novartis quarterly results A-TITLE Novartis quarterly results |
/investors/financial-data/sec-... | | Novartis SEC filings A-TITLE Novartis SEC filings |
/investors/financial-data/prod... | | Product sales A-TITLE Product sales |
/investors/financial-data/fixe... | | Fixed-income securities A-TITLE Fixed-income securities |
/investors/financial-data/expe... | | Expected currency impact A-TITLE Expected currency impact |
/investors/share-data-analysis | | Share data and analysis A-TITLE Share data and analysis |
/investors/share-data-and-anal... | | Share monitor A-TITLE Share monitor |
/investors/share-data-and-anal... | | Dividend information A-TITLE Dividend information |
/investors/share-data-and-anal... | | Share ownership A-TITLE Share ownership |
/investors/share-data-analysis... | | Share overview A-TITLE Share overview |
/investors/share-data-and-anal... | | Return on investment calculator A-TITLE Return on investment calculator |
/investors/shareholder-informa... | | Shareholder information A-TITLE Shareholder information |
/investors/shareholder-informa... | | General Meetings A-TITLE General Meetings |
/investors/shareholder-informa... | | American Depositary Receipts (ADR) A-TITLE American Depositary Receipts (ADR) |
/investors/shareholder-informa... | | Share buyback A-TITLE Share buyback |
/investors/shareholder-informa... | | Frequently asked questions A-TITLE Frequently asked questions |
/investors/company-overview | | Company overview A-TITLE Company overview |
/investors/company-overview/co... | | Corporate governance A-TITLE Corporate governance |
/investors/reporting-and-trans... | Textduplikat | Reporting and transparency hub A-TITLE Reporting and transparency hub |
/investors/reporting-and-trans... | Textduplikat | Novartis in Society Integrated Report A-TITLE Novartis in Society Integrated Report |
/investors/reporting-and-trans... | | Reporting archive A-TITLE Reporting archive |
/investors/reporting-and-trans... | Textduplikat | ESG rating performance A-TITLE ESG rating performance |
/news/stay-up-to-date | | Publications order form A-TITLE Publications order form |
https://www.novartis.com/esg | Textduplikat | ESG A-TITLE ESG |
https://www.novartis.com/news | | News A-TITLE News |
/news/news-archive | | News archive A-TITLE News archive |
/news/media-library | | Media library A-TITLE Media library |
https://www.novartis.com/stories | | Stories A-TITLE Stories |
/news/stay-up-to-date | | Subscribe A-TITLE Subscribe |
/news/events | | Events A-TITLE Events |
https://www.novartis.com/careers | | Careers A-TITLE Careers |
/careers/career-search | | Career search A-TITLE Career search |
/careers/our-business-functions | | Our business functions A-TITLE Our business functions |
/careers/our-business-function... | | Careers in research and development A-TITLE Careers in research and development |
/careers/our-business-function... | | Careers in operations A-TITLE Careers in operations |
/careers/our-business-function... | | Careers in commercial and sales A-TITLE Careers in commercial and sales |
/careers/our-business-function... | | Careers in global functions A-TITLE Careers in global functions |
/careers/why-novartis | | Why Novartis A-TITLE Why Novartis |
/careers/career-hub | | Career hub A-TITLE Career hub |
https://novartis.willhire.co/ | Neues Fenster Extern Subdomain | Temporary contracts A-TITLE Temporary contracts |
/careers/early-careers | | Early careers A-TITLE Early careers |
/careers/early-careers/graduates | | Graduates A-TITLE Graduates |
/careers/early-careers/students | | Students A-TITLE Students |
/careers/early-careers/us-biom... | | US Biomedical Research internship programs A-TITLE US Biomedical Research internship programs |
/careers/early-careers/communi... | | Community exploration and learning lab (CELL) A-TITLE Community exploration and learning lab (CELL) |
/clinicaltrials | | Clinical trials A-TITLE Clinical trials |
/partnering | | Partnering A-TITLE Partnering |
/supplier-portal | | Supplier portal A-TITLE Supplier portal |
https://www.novartis.com/report | Neues Fenster | Report side effects A-TITLE Report side effects |
https://www.novartis.com/contacts | | Contacts A-TITLE Contacts |
/about/therapeutic-areas | | Discover our medicines Our innovative medicines address society’s greatest disease burdens and restore possibility for patients. IMG-ALT Two men, seated indoors around a table, engaged in a conversation and playing chess |
/research-and-development | | Explore our science Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives. IMG-ALT A female research scientist in a lab looking at a sample |
/news/events/novartis-financia... | | Learn more A-TITLE Learn more |
/news/official-partner-eurovis... | Textduplikat | Learn more A-TITLE Learn more |
/news/media-releases/novartis-... | | Oct 29, 2024 Media Release Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile |
/news/media-releases/novartis-... | | Oct 29, 2024 Media Release Novartis continues strong momentum in Q3 with 10% sales growth, 20% core operating income growth, and important innovation milesto... |
/news/media-releases/novartis-... | | Oct 27, 2024 Media Release Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial |
/news/news-archive | | All news A-TITLE All news |
/investors/reporting-and-trans... | | View the online summary A-TITLE View the online summary |
https://www.novartis.com/careers | | Welcome to where we thrive together A-TITLE Welcome to where we thrive together |
https://www.novartis.com/careers | | Join us A-TITLE Join us |
https://www.novartis.com/about | | About Novartis A-TITLE About Novartis |
/healthcare-professionals | Textduplikat | Healthcare professionals A-TITLE Healthcare professionals |
/patients-and-caregivers | Textduplikat | Patients and caregivers A-TITLE Patients and caregivers |
/research-development/novartis... | | Pipeline A-TITLE Pipeline |
/about/products | Textduplikat | Products A-TITLE Products |
/patients-and-caregivers | Textduplikat | Patients and caregivers |
/healthcare-professionals | Textduplikat | Healthcare professionals |
/research-and-development | | Researchers |
https://www.novartis.com/careers | | Job seekers |
https://www.novartis.com/news | | Journalists |
/investors | Textduplikat | Investors |
/news/events/novartis-financia... | | Q3 2024 |
/esg/access | Textduplikat | Access |
/about/diversity-equity-and-in... | | Diversity |
https://www.novartis.com/esg | Textduplikat | ESG |
/esg/ethics-risk-and-complianc... | | SpeakUp |
/research-development/novartis... | Textduplikat | Pipeline |
/about/products | Textduplikat | Products |
/clinicaltrials | Textduplikat | Clinical trials |
/partnering | Textduplikat | Partnering |
https://www.novartis.com/stories | Textduplikat | Stories |
/about/therapeutic-areas/cardi... | Textduplikat | Cardiovascular, renal and metabolic |
/about/therapeutic-areas/immun... | Textduplikat | Immunology |
/about/therapeutic-areas/neuro... | Textduplikat | Neuroscience |
/about/therapeutic-areas/oncology | Textduplikat | Oncology |
https://www.linkedin.com/compa... | Neues Fenster Extern Subdomain | A-TITLE LinkedIn |
https://www.facebook.com/novartis | Neues Fenster Extern Subdomain | A-TITLE Facebook |
https://x.com/novartis | Neues Fenster Extern | A-TITLE X formerly known as Twitter |
https://www.instagram.com/nova... | Neues Fenster Extern Subdomain | A-TITLE Instagram |
https://www.youtube.com/user/n... | Neues Fenster Extern Subdomain | A-TITLE Youtube |
/terms-use | | Terms of use |
https://www.novartis.com/privacy | | Privacy |
https://www.novartis.com/ | Anchor | Cookie settings |
https://www.novartis.com/contacts | Textduplikat | Contacts |
/about/locations | | Locations |
/sitemap.xml | | Site map |
/open-source | | Open source |
/accessibility | | Web accessibility |
/novartis-directory | | Novartis Site Directory A-TITLE Novartis Site Directory |
(Nice to have)